p53 represses class switch recombination to IgG2a through its antioxidant function

Journal of Immunology

Volumn 184, Issue 11, 2010, Pages 6177-6187

  Guikema, Jeroen E J ^a   Schrader, Carol E ^a   Brodsky, Michael H ^a   Linehan, Erin K ^a   Richards, Adam ^a   El Falaky, Nahla ^a   Li, Daniel H ^b   Sluss, Hayla K ^a   Szomolanyi Tsuda, Eva ^a   Stavnezer, Janet ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b AnaSpec   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G2A; PROTEIN P53; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT; CYTIDINE DEAMINASE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL ISOLATION; CELL SURVIVAL; DNA STRAND BREAKAGE; GENE EXPRESSION; GENE MUTATION; GENE SWITCHING; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL SEPARATION; DOUBLE STRANDED DNA BREAK; FLOW CYTOMETRY; GENE REARRANGEMENT; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL SEPARATION; CYTIDINE DEAMINASE; DNA BREAKS, DOUBLE-STRANDED; FLOW CYTOMETRY; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953425540     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904085     Document Type: Article

References (70)

1. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
2. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
3. Petersen, S., R. Casellas, B. Reina-San-Martin, H. T. Chen, M. J. Difilippantonio, P. C. Wilson, L. Hanitsch, A. Celeste, M. Muramatsu, D. R. Pilch, et al. 2001. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 414: 660-665.
4. Rush, J. S., S. D. Fugmann, and D. G. Schatz. 2004. Staggered AID-dependent DNA double strand breaks are the predominant DNA lesions targeted to S mu in Ig class switch recombination. Int. Immunol. 16: 549-557.
5. Schrader, C. E., E. K. Linehan, S. N. Mochegova, R. T. Woodland, and J. Stavnezer. 2005. Inducible DNA breaks in Ig S regions are dependent on AID and UNG. J. Exp. Med. 202: 561-568.
6. Catalan, N., F. Selz, K. Imai, P. Revy, A. Fischer, and A. Durandy. 2003. The block in immunoglobulin class switch recombination caused by activation-induced cytidine deaminase deficiency occurs prior to the generation of DNA double strand breaks in switch mu region. J. Immunol. 171: 2504-2509.
7. Petersen-Mahrt, S. K., R. S. Harris, and M. S. Neuberger. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418: 99-103.
8. Schrader, C. E., J. Vardo, and J. Stavnezer. 2002. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J. Exp. Med. 195: 367-373.
9. Rada, C., J. M. Di Noia, and M. S. Neuberger. 2004. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16: 163-171.
10. Peled, J. U., F. L. Kuang, M. D. Iglesias-Ussel, S. Roa, S. L. Kalis, M. F. Goodman, and M. D. Scharff. 2008. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26: 481-511.
11. Stavnezer, J., and C. E. Schrader. 2006. Mismatch repair converts AID-instigated nicks to double-strand breaks for antibody class-switch recombination. Trends Genet. 22: 23-28.
12. Stavnezer, J., J. E. Guikema, and C. E. Schrader. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26: 261-292.
13. Schrader, C. E., J. E. Guikema, E. K. Linehan, E. Selsing, and J. Stavnezer. 2007. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J. Immunol. 179: 6064-6071.
14. Reina-San-Martin, B., H. T. Chen, A. Nussenzweig, and M. C. Nussenzweig. 2004. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med. 200: 1103-1110.
15. Reina-San-Martin, B., S. Difilippantonio, L. Hanitsch, R. F. Masilamani, A. Nussenzweig, and M. C. Nussenzweig. 2003. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197: 1767-1778.
16. Lumsden, J. M., T. McCarty, L. K. Petiniot, R. Shen, C. Barlow, T. A. Wynn, H. C. Morse, 3rd, P. J. Gearhart, A. Wynshaw-Boris, E. E. Max, and R. J. Hodes. 2004. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 200: 1111-1121.
17. Manis, J. P., J. C. Morales, Z. Xia, J. L. Kutok, F. W. Alt, and P. B. Carpenter. 2004. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat. Immunol. 5: 481-487.
18. Kracker, S., Y. Bergmann, I. Demuth, P. O. Frappart, G. Hildebrand, R. Christine, Z. Q. Wang, K. Sperling, M. Digweed, and A. Radbruch. 2005. Nibrin functions in Ig class-switch recombination. Proc. Natl. Acad. Sci. USA 102: 1584-1589.
19. Dinkelmann, M., E. Spehalski, T. Stoneham, J. Buis, Y. Wu, J. M. Sekiguchi, and D. O. Ferguson. 2009. Multiple functions of MRN in end-joining pathways during isotype class switching. Nat. Struct. Mol. Biol. 16: 808-813.
20. Reina-San-Martin, B., M. C. Nussenzweig, A. Nussenzweig, and S. Difilippantonio. 2005. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc. Natl. Acad. Sci. USA 102: 1590-1595.
21. Pan-Hammarström, Q., A. Lähdesmäki, Y. Zhao, L. Du, Z. Zhao, S. Wen, V. L. Ruiz-Perez, D. K. Dunn-Walters, J. A. Goodship, and L. Hammarström. 2006. Disparate roles of ATR and ATM in immunoglobulin class switch recombination and somatic hypermutation. J. Exp. Med. 203: 99-110.
22. Lähdesmäki, A., A. M. Taylor, K. H. Chrzanowska, and Q. Pan-Hammarström. 2004. Delineation of the role of the Mre11 complex in class switch recombination. J. Biol. Chem. 279: 16479-16487.
23. Sancar, A., L. A. Lindsey-Boltz, K. Unsal-Kaçmaz, and S. Linn. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73: 39-85.
24. Sablina, A. A., A. V. Budanov, G. V. Ilyinskaya, L. S. Agapova, J. E. Kravchenko, and P. M. Chumakov. 2005. The antioxidant function of the p53 tumor suppressor. Nat. Med. 11: 1306-1313.
25. Bensaad, K., A. Tsuruta, M. A. Selak, M. N. Vidal, K. Nakano, R. Bartrons, E. Gottlieb, and K. H. Vousden. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120.
26. Johnson, T. M., Z. X. Yu, V. J. Ferrans, R. A. Lowenstein, and T. Finkel. 1996. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 93: 11848-11852.
27. Snider, M. J., L. Reinhardt, R. Wolfenden, and W. W. Cleland. 2002. 15N kinetic isotope effects on uncatalyzed and enzymatic deamination of cytidine. Biochemistry 41: 415-421.
28. Labet, V., A. Grand, J. Cadet, and L. A. Eriksson. 2008. Deamination of the radical cation of the base moiety of 2′-deoxycytidine: a theoretical study. ChemPhysChem 9: 1195-1203.
29. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
30. Armata, H. L., D. S. Garlick, and H. K. Sluss. 2007. The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. Cancer Res. 67: 11696-11703.
31. Phelan, S. A., X. Wang, P. Wallbrandt, K. Forsman-Semb, and B. Paigen. 2003. Overexpression of Prdx6 reduces H2O2 but does not prevent diet-induced atherosclerosis in the aortic root. Free Radic. Biol. Med. 35: 1110-1120.
32. Schrader, C. E., W. Edelmann, R. Kucherlapati, and J. Stavnezer. 1999. Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J. Exp. Med. 190: 323-330.
33. Guikema, J. E., E. K. Linehan, D. Tsuchimoto, Y. Nakabeppu, P. R. Strauss, J. Stavnezer, and C. E. Schrader. 2007. APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination. J. Exp. Med. 204: 3017-3026.
34. Szomolanyi-Tsuda, E., Q. P. Le, R. L. Garcea, and R. M. Welsh. 1998. T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J. Virol. 72: 6665-6670.
35. Vassilev, L. T., B. T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, C. Klein, et al. 2004. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844-848.
36. Vousden, K. H., and C. Prives. 2009. Blinded by the Light: The Growing Complexity of p53. Cell 137: 413-431.
37. Crighton, D., S. Wilkinson, J. O'Prey, N. Syed, P. Smith, P. R. Harrison, M. Gasco, O. Garrone, T. Crook, and K. M. Ryan. 2006. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-134.
38. Takizawa, M., H. Tolarová, Z. Li, W. Dubois, S. Lim, E. Callen, S. Franco, M. Mosaico, L. Feigenbaum, F. W. Alt, et al. 2008. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J. Exp. Med. 205: 1949-1957.
39. Sernández, I. V., V. G. de Yébenes, Y. Dorsett, and A. R. Ramiro. 2008. Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo. PLoS ONE 3: e3927.
40. Zhou, J., J. Ahn, S. H. Wilson, and C. Prives. 2001. A role for p53 in base excision repair. EMBO J. 20: 914-923.
41. Seo, Y. R., M. L. Fishel, S. Amundson, M. R. Kelley, and M. L. Smith. 2002. Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene 21: 731-737.
42. Wu, X., and J. Stavnezer. 2007. DNA polymerase beta is able to repair breaks in switch regions and plays an inhibitory role during immunoglobulin class switch recombination. J. Exp. Med. 204: 1677-1689.
43. Kim, K. S., K. W. Kang, Y. B. Seu, S. H. Baek, and J. R. Kim. 2009. Interferongamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech. Ageing Dev. 130: 179-188.
44. Sasaki, M., H. Ikeda, Y. Sato, and Y. Nakanuma. 2008. Proinflammatory cytokine- induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study. Free Radic. Res. 42: 625-632.
45. Mann-Chandler, M. N., M. Kashyap, H. V. Wright, F. Norozian, B. O. Barnstein, S. Gingras, E. Parganas, and J. J. Ryan. 2005. IFN-gamma induces apoptosis in developing mast cells. J. Immunol. 175: 3000-3005.
46. Zhang, H. M., J. Yuan, P. Cheung, D. Chau, B. W. Wong, B. M. McManus, and D. Yang. 2005. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Mol. Cell. Biol. 25: 6247-6258.
47. Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679.
48. Banin, S., L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677.
49. Khanna, K. K., K. E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan, S. P. Lees-Miller, and M. F. Lavin. 1998. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 20: 398-400.
50. Sluss, H. K., H. Armata, J. Gallant, and S. N. Jones. 2004. Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol. Cell. Biol. 24: 976-984.
51. Yang, D., S. G. Elner, Z. M. Bian, G. O. Till, H. R. Petty, and V. M. Elner. 2007. Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp. Eye Res. 85: 462-472.
52. Sonoda, J., J. Laganière, I. R. Mehl, G. D. Barish, L. W. Chong, X. Li, I. E. Scheffler, D. C. Mock, A. R. Bataille, F. Robert, et al. 2007. Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense. Genes Dev. 21: 1909-1920.
53. Singh, D. K., D. Kumar, Z. Siddiqui, S. K. Basu, V. Kumar, and K. V. Rao. 2005. The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. Cell 121: 281-293.
54. Moiseeva, O., F. A. Mallette, U. K. Mukhopadhyay, A. Moores, and G. Ferbeyre. 2006. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol. Biol. Cell 17: 1583-1592.
55. Liu, B., Y. Chen, and D. K. St Clair. 2008. ROS and p53: a versatile partnership. Free Radic. Biol. Med. 44: 1529-1535.
56. Josse, C., S. Legrand-Poels, B. Piret, F. Sluse, and J. Piette. 1998. Impairment of the mitochondrial electron chain transport prevents NF-kappa B activation by hydrogen peroxide. Free Radic. Biol. Med. 25: 104-112.
57. Asehnoune, K., D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham. 2004. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J. Immunol. 172: 2522-2529.
58. Budanov, A. V., T. Shoshani, A. Faerman, E. Zelin, I. Kamer, H. Kalinski, S. Gorodin, A. Fishman, A. Chajut, P. Einat, et al. 2002. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21: 6017-6031.
59. Kelly, G. S. 1998. Clinical applications of N-acetylcysteine. Altern. Med. Rev. 3: 114-127.
60. Lu, H. R., H. Zhu, M. Huang, Y. Chen, Y. J. Cai, Z. H. Miao, J. S. Zhang, and J. Ding. 2005. Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase. Mol. Pharmacol. 68: 983-994.
61. Cook, A. J., L. Oganesian, P. Harumal, A. Basten, R. Brink, and C. J. Jolly. 2003. Reduced switching in SCID B cells is associated with altered somatic mutation of recombined S regions. J. Immunol. 171: 6556-6564.
62. Ramiro, A. R., M. Jankovic, E. Callen, S. Difilippantonio, H. T. Chen, K. M. McBride, T. R. Eisenreich, J. Chen, R. A. Dickins, S. W. Lowe, et al. 2006. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440: 105-109.
63. Phan, R. T., and R. Dalla-Favera. 2004. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432: 635-639.
64. Phan, R. T., M. Saito, K. Basso, H. Niu, and R. Dalla-Favera. 2005. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol. 6: 1054-1060.
65. Franco, S., M. M. Murphy, G. Li, T. Borjeson, C. Boboila, and F. W. Alt. 2008. DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination. J. Exp. Med. 205: 557-564.
66. Jankovic, M., D. F. Robbiani, Y. Dorsett, T. Eisenreich, Y. Xu, A. Tarakhovsky, A. Nussenzweig, and M. C. Nussenzweig. 2009. Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proc Natl Acad Sci U S A. 107; 187-192.
67. Liu, Y., S. E. Elf, Y. Miyata, G. Sashida, Y. Liu, G. Huang, S. Di Giandomenico, J. M. Lee, A. Deblasio, S. Menendez, et al. 2009. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4: 37-48.
68. Hu, W., Z. Feng, A. K. Teresky, and A. J. Levine. 2007. p53 regulates maternal reproduction through LIF. Nature 450: 721-724.
69. Salvador, J. M., M. C. Hollander, A. T. Nguyen, J. B. Kopp, L. Barisoni, J. K. Moore, J. D. Ashwell, and A. J. Fornace, Jr. 2002. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16: 499-508.
70. Leech, M., J. R. Xue, A. Dacumos, P. Hall, L. Santos, Y. Yang, M. Li, A. R. Kitching, and E. F. Morand. 2008. The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response. Clin. Exp. Immunol. 152: 345-353.